Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes

作者: Ja-Lok Ku , Kyung-Hee Kim , Jin-Sung Choi , You-Kyung Jeon , Sung-Hee Kim

DOI: 10.1007/S13402-010-0004-6

关键词:

摘要: Six human lung cancer cell lines (SNU-371, SNU-963, SNU-1327, SNU-1330, SNU-2292 and SNU-2315) were newly established through primary cultures. These derived from a pulmonary blastoma, small cancer, three adenocarcinomas squamous carcinoma of the six Korean patients. The histopathology tumors their in vitro growth characteristics described. DNA fingerprinting analysis genetic alterations p53, β-catenin, TGFβRII, K-ras EGFR genes conducted. mRNA expressions levels E-cadherin, COX-2, MDR1, MXR, CGA, synatophysin TTF1 investigated sensitivity to anticancer drugs was screened. Five grew as adherent cells one line floating aggregates. All free mycoplasma or bacteria proven unique by analysis. A significant polymorphism at codon 72 (Arg Pro) p53 gene found (SNU-1327) mutation 176 SNU-2292. No mutations K-ras, β-catenin TGF-βRII observed. E-cadherin not expressed SNU-371 COX-2 overexpressed SNU-2315 lines. MDR1 MXR SNU-1327 line. Interestingly, blastoma which displayed cross resistance for several drugs. Neuroendocrine markers, chromogranin synaptophysin, line, SNU-963 thyroid transcription factor-1 also over this Two (p.Glu746_Ser752delinsVal p.Glu746_Ala750del) exon 19 SNU-1330 lines, respectively. well-characterized may be useful tools investigations biological cancers, particularly related EGFR.

参考文章(38)
S Hougaard, P Nørgaard, N Abrahamsen, H L Moses, M Spang-Thomsen, H Skovgaard Poulsen, Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines British Journal of Cancer. ,vol. 79, pp. 1005- 1011 ,(1999) , 10.1038/SJ.BJC.6690161
Miyu Miwa, Satomi Tsukahara, Etsuko Ishikawa, Sakiyo Asada, Yasuo Imai, Yoshikazu Sugimoto, Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants. International Journal of Cancer. ,vol. 107, pp. 757- 763 ,(2003) , 10.1002/IJC.11484
C. Ostwald, P. Gogacz, T. Hillmann, J. Schweder, K. Gundlach, G. Kundt, M. Barten, p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity. International Journal of Cancer. ,vol. 88, pp. 82- 86 ,(2000) , 10.1002/1097-0215(20001001)88:1<82::AID-IJC13>3.0.CO;2-N
Jan H. M. Schellens, Susan E. Bates, Murugesan K. Gounder, Patrick Sinko, Rajeev Rajendra, Eric H. Rubin, Douglas D. Ross, Ahamed Saleem, Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin. Cancer Research. ,vol. 63, pp. 3228- 3233 ,(2003)
John D. Minna, Adi F. Gazdar, Martin Brower, Herbert K. Oie, Desmond N. Carney, Growth of Cell Lines and Clinical Specimens of Human Non-Small Cell Lung Cancer in a Serum-free Defined Medium Cancer Research. ,vol. 46, pp. 798- 806 ,(1986)
Yasuo Miyoshi, Masao Kameyama, Moritoshi Kinoshita, Syoji Nakamori, Shingo Ishiguro, Shingi Imaoka, Yusuke Nakamura, Kyoko Iwao, Takafumi Fukui, Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations Cancer Research. ,vol. 58, pp. 1021- 1026 ,(1998)
Sae-Won Han, Tae-You Kim, Pil Gyu Hwang, Soohyun Jeong, Jeongmi Kim, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Dong-Wan Kim, Doo Hyun Chung, Seock-Ah Im, Young Tae Kim, Jong Seok Lee, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim, Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib Journal of Clinical Oncology. ,vol. 23, pp. 2493- 2501 ,(2005) , 10.1200/JCO.2005.01.388
Junichi Kurebayashi, Katsuhiro Tanaka, Takemi Otsuki, Takuya Moriya, Hironori Kunisue, Masako Uno, Hiroshi Sonoo, All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1. The Journal of Clinical Endocrinology and Metabolism. ,vol. 85, pp. 2889- 2896 ,(2000) , 10.1210/JCEM.85.8.6732
Shiu-Feng Huang, Hui-Ping Liu, Ling-Hui Li, Yuan-Chieh Ku, Yu-Ning Fu, Hsien-Yu Tsai, Ya-Ting Chen, Yung-Feng Lin, Wen-Cheng Chang, Han-Pin Kuo, Yi-Cheng Wu, Yi-Rong Chen, Shih-Feng Tsai, High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan Clinical Cancer Research. ,vol. 10, pp. 8195- 8203 ,(2004) , 10.1158/1078-0432.CCR-04-1245
J.-G. Park, S.-K. Lee, I.-G. Hong, H.-S. Kim, K.-H. Lim, K.-J. Choe, W.-H. Kim, Y.-I. Kim, T. Tsuruo, M. M. Gottesman, MDR1 Gene Expression: Its Effect on Drug Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cell Lines Journal of the National Cancer Institute. ,vol. 86, pp. 700- 705 ,(1994) , 10.1093/JNCI/86.9.700